In its effort to increase point-of-service collections and improve the overall revenue cycle, Sutter Health took steps to: Measure performance using a handful of specific, primary benchmarks. Empower PFS staff to assume responsibility for every individual account they handle. Ensure each registration is analyzed using a rules engine to identify problems before patients leave the registration desk. Ensure PFS staff receive appropriate comprehensive training to excel under the new system.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Comparative Efficacy of Lenvatinib Plus Immunotherapy and Regorafenib Plus Immunotherapy After Lenvatinib Failure for Advanced Hepatocellular Carcinoma: A Retrospective Study.
Drugs Real World Outcomes
January 2025
Interventional Radiology Department, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Background: The combination of regorafenib and immune checkpoint inhibitor (ICI) has been the most popular second-line systemic therapy for advanced hepatocellular carcinoma (HCC). However, considering the good anti-tumor performance of lenvatinib, combined immunotherapy on the basis of lenvatinib after first-line lenvatinib failure is also popular in clinical practice. This study aimed to compare the efficacy and safety of regorafenib plus ICI (TACE-R-I) versus lenvatinib plus ICI (TACE-L-I) in patients with advanced HCC after lenvatinib failure.
View Article and Find Full Text PDFThe prognostic and immunomodulatory role of the MMR system in patients with stomach adenocarcinoma.
Sci Rep
January 2025
Department of Gastroenterology, Shanxi Hospital Affiliated to Cancer Hospital, Shanxi Province Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan City, 030013, Shanxi Province, China.
The mismatch repair (MMR) system plays a crucial role in the maintenance of DNA replication fidelity and genomic stability. The clinical value of the MMR molecular marker as an immunotherapy for advanced solid tumors has been documented. However, this therapy is not effective in some patients.
View Article and Find Full Text PDFExamining the Reliability and Validity of Coding Perceived Force Severity and Bracing in the NHL Concussion Spotter Program.
Orthop J Sports Med
November 2024
Department of Biomedical and Health Informatics, University of Missouri-Kansas City, Kansas City, Missouri, USA.
Background: Data obtained from the National Hockey League (NHL) have shown that a risk prediction model, including both visible signs and mechanisms of injury, improves the identification of possible concussion. However, only about half of concussions diagnosed by club medical staff in the NHL exhibit visible signs. At present, the NHL concussion spotter protocol does not include central league spotters' subjective judgments of the severity of forces associated with a direct hit to the head (perceived force severity [PFS]) or whether players brace before a hit (bracing).
View Article and Find Full Text PDFNew emerging treatment options for metastatic melanoma: a systematic review and meta-analysis of skin cancer therapies.
Arch Dermatol Res
November 2024
Faculty of Pharmacy, Al-Quds University, Abu Deis, P.O. Box 20002, Jerusalem, Palestine.
Skin cancer, notably melanoma, poses a significant global health burden, with rising incidence and mortality rates. While therapeutic advancements have improved outcomes, metastatic melanoma remains challenging to treat. This study aims to systematically review systemic treatment options for advanced melanoma, focusing on efficacy and safety in the first-line setting.
View Article and Find Full Text PDFMorphomics, Survival, and Metabolites in Patients With Metastatic Pancreatic Cancer.
JAMA Netw Open
October 2024
Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor.
Article Synopsis
- - This study explores how Body Mass Index (BMI) and body composition (morphomics) relate to survival rates in patients with metastatic pancreatic ductal adenocarcinoma (PDA), highlighting variability in previous research.
- - Conducted during a phase 3 clinical trial involving 528 patients across multiple countries, the study collected extensive patient data and used imaging to analyze body composition and serum metabolites for better survival predictions.
- - Findings showed that higher BMI (specifically obesity) wasn't linked to overall survival, while an increase in subcutaneous fat was associated with better outcomes, indicating that factors beyond BMI, like body composition, may play a crucial role in patient survival.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!